Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Transfusion. 2010 Dec;50(12):2738–2744. doi: 10.1111/j.1537-2995.2010.02748.x

Table 1. Transfusion reaction incidence pre- and post-implementation of universal leukoreduction (ULR).

Pre–universal
leukoreduction
(n; incidence)
1993-1999
Post–universal
leukoreduction
(n; incidence)
2001-2007
Odds Ratio
Post-/Pre-ULR
(95% confidence
interval)
Net
Change In
Incidence
p value
(incidence
pre/post-
ULR)
Transfused
Components
362,784 415,775 ------ ----- -----
TRALI
cases
10 (2.8*) 2 (0.48*) 0.17 (0.04-0.80) −83% 0.01
TACO cases 27 (7.4*) 16 (3.8*) 0.52 (0.28-0.96) −49% 0.03
Allergic
Reactions
255 (7.0) 290 (7.0) 0.99 (0.84-1.17) 0% 0.96
Fever/Rigor
Reactions
413 (11.4) 309 (7.4) 0.65 (0.56-0.76) −35% <0.0001
*

Rate per 100,000 components transfused

Rate per 10,000 components transfused